The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Oncology (Inst); TESARO (Inst); VBL Therapeutics (Inst)
Research Funding - Lilly (Inst); PTC Therapeutics (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Angeles Alvarez Secord
Honoraria - Alexion Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Myriad Pharmaceuticals; Tesaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Myriad Genetics; Tesaro
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Incyte (Inst); Merck (Inst); Morphotek (Inst); PharmaMar (Inst); Prima BioMed (Inst); Tesaro (Inst)
 
Melissa Ann Geller
Speakers' Bureau - Tesaro
Research Funding - Bayer; FATE Therapeutics; Genentech; Morphotek; Ovagene Oncology; Tesaro
 
David S. Miller
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca; Clovis Oncology; Eisai; Genentech; Guardant Health; ImmunoGen; Tesaro
Speakers' Bureau - Clovis Oncology; Genentech
Research Funding - Aeterna Zentaris; Aprea AB; AstraZeneca; Genentech; ImmunoGen; Janssen; Pfizer; Takeda; Tesaro; TRACON Pharma; Xenetic Biosciences
 
Noelle Gillette Cloven
Employment - Texas Oncology
Research Funding - Tesaro
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Masoud Azodi
No Relationships to Disclose
 
Paul DiSilvestro
Consulting or Advisory Role - AstraZeneca; Tesaro
Research Funding - Abbvie; AstraZeneca; Genentech; Janssen; Roche; Tesaro
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Mihaela C. Cristea
No Relationships to Disclose
 
Jonathan S. Berek
Consulting or Advisory Role - Atara Biotherapeutics
Research Funding - Tesaro (Inst)
 
John K. Chan
Honoraria - AstraZeneca; Clovis Oncology; Genentech/Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology; Janssen Oncology; Mateon Therapeutics; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
 
Yong Li
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Romnee Clark
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Ursula A. Matulonis
Consulting or Advisory Role - 2X Oncology; Clovis Oncology; Fujifilm; Geneos; Lilly; Merck; Myriad Genetics
Research Funding - Merck; Novartis
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)